Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997

P Burgard1, H J Bremer, P Bührdel

  • 1Fachrichtung Psychologie, Universität des Saarlandes, Im Stadtwald, Saarbrücken, Germany. p.burgard@cops.uni-sb.de

European Journal of Pediatrics
|February 9, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Die Ophthalmologie·2026
Same author

[Limbal diseases].

Die Ophthalmologie·2026
Same author

Chemoproteomic Profiling of PKA Substrates with Kinase-catalyzed Crosslinking and Immunoprecipitation (K-CLIP).

bioRxiv : the preprint server for biology·2025
Same author

Terahertz Radiation Driven Nonlinear Transport Phenomena in Two-Dimensional Tellurene.

Nano letters·2024
Same author

Resistance or tolerance? Highlighting the need for precise terminology in the field of disinfection.

The Journal of hospital infection·2024
Same author

Material risk: vitreoretinal surgery, evisceration, enucleation and sympathetic ophthalmia-where are we currently?

Eye (London, England)·2023

Early and strict treatment of phenylketonuria (PKU) with a low phenylalanine diet leads to near-normal development. Lifelong monitoring is crucial due to potential unknown late effects.

Area of Science:

  • Metabolic disorders
  • Neurodevelopmental disorders
  • Genetics

Background:

  • Phenylketonuria (PKU) is a genetic disorder requiring dietary management.
  • Low phenylalanine (Phe) diets are effective in preventing neurological issues in PKU patients.
  • Treatment recommendations for adolescent and adult PKU patients vary internationally.

Purpose of the Study:

  • To evaluate research on outcomes in PKU patients.
  • To formulate evidence-based recommendations for PKU treatment across different age groups.
  • To address variability in current international treatment guidelines.

Main Methods:

  • Systematic review of research on IQ, speech, behavior, education, and neuroimaging in PKU patients.
  • Evaluation of clinical neurology and electroencephalography data.

Related Experiment Videos

  • Formulation of provisional treatment recommendations based on current knowledge.

    • Main Results:

    • Early and strict PKU treatment results in almost normal development.
    • Recommended blood Phe levels are 40-240 micromol/L for the first 10 years.
    • Treatment can be gradually relaxed after age 10, with lifelong follow-up advised.

    Conclusions:

    • Early and strict management of phenylketonuria ensures near-normal development.
    • Lifelong patient follow-up is essential for monitoring potential unknown long-term sequelae.
    • Comprehensive PKU management includes dietary training, counseling, and outcome monitoring.